To support quality improvement (QI) projects in breast cancer, the Association of Community Cancer Centers (ACCC) has partnered with Pfizer Global Medical Grants to award more than $1.8 million in funding to 15 projects that are aimed at improving the quality of breast cancer patient care. The projects will focus on conducting quality improvement (QI) initiatives that support increasing the rates of BRCA testing for patients with early stage or metastatic breast cancer.
Grants proposals were solicited through a Request for Proposal (RFP) issued by ACCC together with Pfizer Global Medical Grants with the intent of funding QI initiatives that fully integrate BRCA testing into patient care plans in order to help inform the treatment decision-making process.
Learn about open opportunities to participate in an ACCC-supported QI project, then see how ACCC's online self-assessment tools can help identify areas of improvement at your program or practice.
Breast, Ovarian Screening Questionnaire Reveals Just 1 in 5 Women Meet NCCN Criteria for Genetic Testing - via Targeted Oncology
Telementoring Program Aims to Improve Quality of Breast Cancer Care - via NewsWise
Randall A. Oyer, MD, explains how ACCC is interpreting the data on genetics presented at ASCO 2018 - via OBR
Presented at the 2021 ASCO Annual Meeting
Presented at the 2020 ASCO Quality Care Symposium.
Presented at the 2020 ASCO Virtual Scientific Program
The projects will launch in January 2019 and will continue for two years. In early 2020, ACCC will begin sharing the results from these QI projects.
Questions? Please contact the BRCA Project Coordinator.
Supported by a grant from Pfizer, Inc.